John S. Montalbano serves as Executive at AbCellera Biologics Inc., where they oversee executive responsibilities. Since joining the company, John S. Montalbano has executed 6 insider transactions totaling $685.7K, demonstrating a bullish approach to their equity position. Their most recent transaction on Nov 26, 2025 involved purchasing 50,000 shares valued at $178.5K.
John S. Montalbano currently holds 221,000 shares of AbCellera Biologics Inc. (ABCL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John S. Montalbano has been a net buyer of ABCL stock. They have purchased $685.7K and sold $0 worth of shares.
John S. Montalbano's most recent insider trade was on Nov 26, 2025, when they purchased 50,000 shares at $3.57 per share.
Get notified when new Form 4 filings are submitted
| $4.46 |
| Discretionary |
| Nov 6, 2023 | ABCL | $92.8K | Purchase | 20,000 | $4.64 | Discretionary |
| Mar 4, 2022 | ABCL | $85.4K | Purchase | 10,000 | $8.54 | Discretionary |
| Mar 1, 2022 | ABCL | $181.0K | Purchase | 20,000 | $9.05 | Discretionary |
| Aug 16, 2021 | ABCL | $103.4K | Purchase | 6,000 | $17.23 | Discretionary |